TokenPost topic

Alesta Therapeutics

1 TokenPost story is tagged Alesta Therapeutics. The newest appear first.

Latest Alesta Therapeutics stories

• BioMarin Sees $1.50 Q3 EPS Hit From Alesta Costs Ahead of Results

  The preliminary estimate includes $283 million in pretax acquired research and development expense. BioMarin plans to update its 2026 outlook when it discusses results Monday, Nov. 2.

  Oct 30, 2026, 3:01 PM EDT · Business